Press-release for stocks published on previous years

Prices are updated after-hours

published : Previous years crawled time : 13:30

save search

Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
Published: 2024-02-09 (Crawled : 13:30) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -3.47% | O: 12.15% H: 262.23% C: 109.44%
solutions financial results

Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com
Published: 2023-12-21 (Crawled : 13:30) - globenewswire.com
CMGR | $0.0003 -50.0% 77K

Health Care and Social Assistan...

| 50.0% | O: -50.0% H: 200.0% C: 100.0%
media

Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023
Published: 2023-11-13 (Crawled : 13:30) - globenewswire.com
TENX | $3.51 0.29% 0.28% 7.9K

Health Technology

| -71.96% | O: 100.38% H: 130.23% C: 98.34%
tnx-103 fda expected treatment clearance hypertension heart therapeutics

Sonim XP8 Smartphone Integrates Walkie Talkie in Microsoft Teams
Published: 2022-03-15 (Crawled : 13:30) - prnewswire.com
SONM 4 | $0.479 0.31% 0.31% 46K

Electronic Technology

| -20.0% | O: 4.98% H: 109.56% C: 93.68%
one smart

Mobivity's Successful Partnerships With Mobile Game Developers Deliver Millions of Consumer Transactions to Brands
Published: 2023-12-29 (Crawled : 13:30) - globenewswire.com
MFON | $0.55 188.57% 1.4K

Information

| 29.41% | O: -48.71% H: 97.25% C: 86.24%
brands mobile

Aptevo Therapeutics Reports First Complete Remission, Providing Clinical Update for Its Phase 1b Multi Center, Multi Cohort Expansion Trial in the Treatment of Acute Myeloid Leukemia
Published: 2021-11-23 (Crawled : 13:30) - biospace.com/
APVO | $0.6827 -7.27% -7.84% 570K

Health Technology

| -90.24% | O: 25.38% H: 132.18% C: 79.07%
treatment myeloid leukemia phase 1 expansion phase 1b leukemia trial therapeutics apvo436 acute myeloid leukemia phase 2b

Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures
Published: 2021-12-08 (Crawled : 13:30) - globenewswire.com
EHVVF | $0.001 155.0% 34K

Professional, Scientific, and T...

| -86.67% | O: 6.67% H: 125.0% C: 71.25%
distribution merge therapy

Sustainable Green Team, Ltd. (SGTM) Announces Its Landmark Accomplishment Obtaining Florida County Contract Awards
Published: 2024-03-27 (Crawled : 13:30) - globenewswire.com
SGTM | $0.701 365.6% 7.6K

n/a

| 117.39% | O: 184.16% H: 320.77% C: 58.47%
contract awards

Kiromic BioPharma Announces Deltacel™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer Center
Published: 2023-11-09 (Crawled : 13:30) - biospace.com/
KRBP | $2.64 -90.21% 360

Health Technology

| 955.58% | O: 3.96% H: 53.85% C: 53.85%
cancer biopharma trial

Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
Published: 2024-03-06 (Crawled : 13:30) - globenewswire.com
NXL | $1.5 -7.69% -8.33% 76K

| 368.79% | O: -1.61% H: 95.85% C: 52.0%
device positive technology results study

Rodedawg Ind. Intl., Inc. Announces New Officers Appointment for Elixicure, LLC
Published: 2024-04-23 (Crawled : 13:30) - globenewswire.com
RWGI | $0.025 66.67% 180K

n/a

| 0.0% | O: -33.33% H: 50.0% C: 50.0%
for

Sidus Space Secures NOAA Approval to Provide Imaging Services to Government and Commercial Customers
Published: 2024-01-03 (Crawled : 13:30) - sidusspace.com
SIDU | $3.47 1.76% 1.73% 56K

| -51.08% | O: 11.76% H: 73.04% C: 49.42%
services approval space commercial imaging

Technicolor: Information concerning the total number of voting rights and shares
Published: 2022-03-07 (Crawled : 13:30) - globenewswire.com
TCLRY | $0.001 1000.0% 140K

Manufacturing

| -99.01% | O: -20.79% H: 48.25% C: 48.25%

Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System
Published: 2021-12-13 (Crawled : 13:30) - biospace.com/
ARTH | $1.14 -17.78% 320

Manufacturing

| 1166.67% | O: -2.11% H: 55.51% C: 46.42%
ac5 contract granted therapeutics grant

Phunware Sets Fourth Quarter and Full Year 2023 Earnings Call for Tuesday, March 12, 2024 at 4:30 PM ET
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
PHUN | $6.31 2.44% 2.38% 520K

Technology Services

| -12.99% | O: 20.34% H: 98.24% C: 45.66%
year

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results
Published: 2024-02-02 (Crawled : 13:30) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| 15.35% | O: 71.78% H: 68.84% C: 43.72%
revenue solutions results

Oatly Announces Nationwide Availability at Insomnia Cookies
Published: 2023-11-16 (Crawled : 13:30) - globenewswire.com
OTLY | $0.9321 -2.91% -2.99% 680K

Manufacturing

| 81.1% | O: 0.17% H: 49.91% C: 43.35%